The National Lung Screening Trial (NLST) was a major clinical trial conducted in the United States to evaluate the effectiveness of low-dose computed tomography (LDCT) scans compared to standard chest X-rays in detecting lung cancer. Initiated in 2002, the trial aimed to determine whether LDCT could reduce mortality rates among high-risk individuals.
